Takeda Pharmaceutical Company Limited vs Royal Caribbean Cruises Ltd.
Market cap comparison over time
Takeda Pharmaceutical Company Limited
$63.9B
Rank #229
Royal Caribbean Cruises Ltd.
$64.9B
Rank #226
Market Cap Over Time
Key Moments
- Royal Caribbean Cruises Ltd. overtook Takeda Pharmaceutical Company Limited by 2019
- Takeda Pharmaceutical Company Limited overtook Royal Caribbean Cruises Ltd. by 2020
- Royal Caribbean Cruises Ltd. overtook Takeda Pharmaceutical Company Limited by 2024
Year-by-Year Comparison
| Year | Takeda Pharmaceutical Company Limited | Royal Caribbean Cruises Ltd. | Leader |
|---|---|---|---|
| 2026 | $63.9B | $64.9B | Royal Caribbean Cruises Ltd. |
| 2025 | $50.3B | $73.8B | Royal Caribbean Cruises Ltd. |
| 2024 | $41.6B | $60.3B | Royal Caribbean Cruises Ltd. |
| 2023 | $38.6B | $33.8B | Takeda Pharmaceutical Company Limited |
| 2022 | $37.6B | $12.9B | Takeda Pharmaceutical Company Limited |
| 2021 | $27.3B | $20.1B | Takeda Pharmaceutical Company Limited |
| 2020 | $31.2B | $19.5B | Takeda Pharmaceutical Company Limited |
| 2019 | $34.2B | $34.3B | Royal Caribbean Cruises Ltd. |
| 2018 | $28.0B | $24.5B | Takeda Pharmaceutical Company Limited |
| 2017 | $46.8B | $29.2B | Takeda Pharmaceutical Company Limited |
| 2016 | $34.2B | $19.7B | Takeda Pharmaceutical Company Limited |
| 2015 | $41.4B | $23.8B | Takeda Pharmaceutical Company Limited |
| 2014 | $33.1B | $19.1B | Takeda Pharmaceutical Company Limited |
| 2013 | $30.8B | $10.8B | Takeda Pharmaceutical Company Limited |
| 2012 | $23.7B | $7.6B | Takeda Pharmaceutical Company Limited |
| 2011 | $19.8B | $5.4B | Takeda Pharmaceutical Company Limited |
| 2010 | $22.3B | $10.3B | Takeda Pharmaceutical Company Limited |
| 2009 | $20.5B | $5.5B | Takeda Pharmaceutical Company Limited |
| 2008 | $23.7B | $3.0B | Takeda Pharmaceutical Company Limited |
| 2007 | $32.5B | $9.1B | Takeda Pharmaceutical Company Limited |
| 2006 | $39.6B | $8.8B | Takeda Pharmaceutical Company Limited |
| 2005 | $30.4B | $9.4B | Takeda Pharmaceutical Company Limited |
| 2004 | $24.2B | $11.2B | Takeda Pharmaceutical Company Limited |
| 2003 | $19.6B | $7.1B | Takeda Pharmaceutical Company Limited |
| 2002 | $22.5B | $3.3B | Takeda Pharmaceutical Company Limited |
| 2001 | $26.6B | $3.1B | Takeda Pharmaceutical Company Limited |
| 2000 | $30.0B | $5.0B | Takeda Pharmaceutical Company Limited |